Literature DB >> 11112390

Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases.

M A Lichtman1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11112390     DOI： 10.1006/bcmd.2000.0335

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  9 in total

1.  Call it cancer: letting the histopathology determine the diagnosis.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2012-04-17

2.  Understanding the mutational evolution of clonal cytopenias and oligoblastic myelogenous leukemia ('myelodysplasia').

Authors:  M A Lichtman
Journal:  Leukemia       Date:  2013-07-11       Impact factor: 11.528

3.  Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2013-08-27

Review 4.  Myelodysplastic syndromes.

Authors:  Olatoyosi Odenike; John Anastasi; Michelle M Le Beau
Journal:  Clin Lab Med       Date:  2011-10-10       Impact factor: 1.935

5.  Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2021-09-12

6.  Possibility of the diagnosis of subacute myeloid leukemia for a group of patients with trisomy 8: a report of 34 cases.

Authors:  Yan Zhang; Jing-Ying Qiu; Yue-Yun Lai; Dao-Pei Lu
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

7.  Cryptic e1a2 BCR-ABL1 fusion with complex chromosomal abnormality in de novo myelodysplastic syndrome.

Authors:  Bo Young Seo; Jun Hyoung Lee; Min Gu Kang; Seok Yong Choi; Soo Hyun Kim; Jong Hee Shin; Soon Pal Suh; Dong Wook Ryang; Myung Geun Shin
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

8.  Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.

Authors:  Katherine L B Knorr; Laura E Finn; B Douglas Smith; Allan D Hess; James M Foran; Judith E Karp; Scott H Kaufmann
Journal:  Stem Cells Transl Med       Date:  2016-11-07       Impact factor: 6.940

Review 9.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.